• Home
  • NEW DAY MEDICINE
  • 2(40)2022
  • 70 -2 (40) 2022 — Oblokulov A.R., Kholov U.A., — MICROBIOLOGICAL INDICATORS OF PATIENTS WITH CONFIRMED COVID-19 INFECTION

70 -2 (40) 2022 — Oblokulov A.R., Kholov U.A., — MICROBIOLOGICAL INDICATORS OF PATIENTS WITH CONFIRMED COVID-19 INFECTION

MICROBIOLOGICAL INDICATORS OF PATIENTS WITH CONFIRMED COVID-19 INFECTION

Oblokulov A.R., Bukhara State Medical institute named after Abu Ali ibn Sino

Kholov U.A., Bukhara regional infectious disease hospital

Djalilova A.S. Bukhara State Medical institute named after Abu Ali ibn Sino

Resume

The article presents a bacteriological analysis of patients admitted to the Bukhara Regional Infectious Diseases Hospital on March 16, 2020 to February 02, 2022 with a diagnosis of COVID-19 coronavirus infection and confirmed SARS-CoV-2 infection (positive real-time RT-PCR, typical for SARS-CoV-2) Results are shown. from fecal samples taken from patients Pr. Vulgaris, Pr. Mirobllis, Kl.phevmoniae, Enterobacter hafniae, from sputum samples of St. Pneumoniae, Can.viridans; S.epidermis, S.aureus were isolated from a blood sample. Most of the isolated microorganisms were sensitive to levofloxacin, amikacin, ciprofloxacin and cefaperazone sulbactam.

Key words: antibiotic resistance; COVID-19; pneumonia; SARS-CoV-2; sputum culture; blood culture.

First page

361

Last page

365

For citation: Oblokulov A.R., Kholov U.A., Djalilova A.S. MICROBIOLOGICAL INDICATORS OF PATIENTS WITH CONFIRMED COVID-19 INFECTION //New Day in Medicine 2(40)2022 361-365 https://cutt.ly/IA9nUHS

LIST OF REFERENCES:

  1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.
  2. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A novel coronavirus from patients with pneumonia in China, 2019. //N Engl J Med 2020; 382:727–33.
  3. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579:270–3.
  4. WHO. Coronavirus disease 2019 (COVID-19)—situation report—51. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10.
  5. Li R., Pei S., Chen B., Song Y., Zhang T., Yang W., et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 202; 368 (6490):489–93.;
  6. Oblokulov A.R., Husenova Z.Z., Ergashev M.M. (2021). Procalcitonin as an indicator of antibacterial therapy in covid-19. //Annals of the Romanian Society for Cell Biology, 5220-5224.
  7. Shen Z., Xiao Y., Kang L., Ma W., Shi L., Zhang L., et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients. //Clin Infect Dis 2020;71:713–20.
  8. Elmurodova A.A. (2022). “Specific Features of the Hemostatic System in Covid-19”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES 3, 82-85.
  9. Martins-Filho P.R., Tavares Cs.S., Santos V.S. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. //Eur J Intern Med 2020;76:97–9.
  10. Oblokulov A.R., Niyozov G.E. (2020). Clinical and epidemiological characteristics of patients with COVID-19  //International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
  11. Priya Nori et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge // Infect Contr and Hospital Epid, 2020. 1-5.
  12. Niyazov G.E., Oblokulov A.R., Pondina A.I., Badieva B.M., Shadieva N.Sh., CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF COVID-19 PATIENTS//New Day in Medicine 4(32)2020 678-681 https://cutt.ly/jz5Y0Ew
  13. MacIntyre C.R., Chughtai A.A., Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a (H1N) // BMC Infect Dis. 2018. 18:637.doi.org/10.1186/s12879-018-3548-0.
  14. Cataño-Correa JC, Cardona-Arias JA, Porras Mancilla JP, García MT (2021) Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE 16(7): e0254671. https://doi.org/10.1371/journal.pone.0254671
  15. Mulcany M.E., McLoughlin R.M. Staphylococcus aureus and influenza A virus: patterns and coinfecrions. VBio. 2016. 7:e02068-16;
  16. Canning B., Sennyake R.V., Burns D., Moran E, Dedicoat M. Post-influenza aspergillus ventriculitis //Clin Infect Pract 2020:100026. doi:10.1016/j.clinpr.2020.100026
  17. Meier M.A., Branche A., Neeser O.L., et al.  Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. Clin Infect Dis 2019; 69:388–96.
  18. Meier M.A., Branche A., Neeser O.L., et al.  Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials. //Clin Infect Dis 2019; 69:388–96.
  19. de Jong E, van Oers JA, Beishuizen A, et al.  Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis 2016; 16:819–27.
  20. Timothy M Rawson, Luke S P Moore, Nina Zhu et al. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing linical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages 2459–2468.

file

download